MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 13, 2005; DOI: 10.1124/mol.105.012906


0026-895X/05/6804-1106-1113$20.00
Mol Pharmacol 68:1106-1113, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.012906v1
68/4/1106    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frenzel, R.
Right arrow Articles by Paschke, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frenzel, R.
Right arrow Articles by Paschke, R.

Sialylation of Human Thyrotropin Receptor Improves and Prolongs Its Cell-Surface Expression

Romy Frenzel, Knut Krohn, Markus Eszlinger, Anke Tönjes, and Ralf Paschke

Medical Department, University of Leipzig, Leipzig, Germany (R.F., K.K., M.E., A.T., R.P.); and Interdisciplinary Center for Clinical Research Leipzig, Leipzig, Germany (K.K.)

Glycosylation of the thyrotropin receptor (TSHR) has been shown to be essential for correct protein folding and for cell-surface targeting. In a recent study, we detected increased expression of {beta}-galactoside {alpha}(2,6)-sialyltransferase (SIAT1) in toxic thyroid adenomas where gain-of-function mutations of the TSHR have been invoked as one of the major causes. To investigate the physiological meaning of these findings, we designed experiments to evaluate the consequences of sialylation for the expression of the TSHR. Hence, we investigated the effect of coexpressing the TSHR and different sialyltransferases (SIAT1, SIAT4a, and SIAT8a) for cell-surface expression of the receptor. Coexpression of each of the three SIAT isoforms and the TSHR in COS-7 cells increased TSHR expression on the cell surface in the range of 50 to 100%. Moreover, Western blot analysis with lectins specific for {alpha}(2,3) and {alpha}(2,6)-linked sialic acids and lectin-binding enzyme-linked immunosorbent assay support a direct effect on TSHR cell-surface expression mediated by sialic acid transfer to the TSHR. Finally, we treated living COS-7 cells after cotransfection of TSHR and SIAT8a with neuraminidase for 30 min to remove covalently linked sialic acid. Subsequent loss of TSHR cell-surface expression suggests that sialylation prolongs the resting time of the TSHR on the cell surface. Our data demonstrate for the first time that the transfer of sialic acid can improve and prolong cell-surface expression of a transmembrane receptor.


Received March 18, 2005; accepted July 13, 2005

Address correspondence to: Dr. R. Paschke, III Medical Department, University of Leipzig, Ph.-Rosenthal-Str. 27, D-04103 Leipzig, Germany. E-mail: pasr{at}medizin.uni-leipzig.de




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
M. Rivas, B. Mellstrom, B. Torres, G. Cali, A. M. Ferrara, D. Terracciano, M. Zannini, G. Morreale de Escobar, and J. R. Naranjo
The DREAM Protein Is Associated with Thyroid Enlargement and Nodular Development
Mol. Endocrinol., June 1, 2009; 23(6): 862 - 870.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Eszlinger, K. Krohn, A. Kukulska, B. Jarzab, and R. Paschke
Perspectives and Limitations of Microarray-Based Gene Expression Profiling of Thyroid Tumors
Endocr. Rev., May 1, 2007; 28(3): 322 - 338.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics